Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Total Valuation

Guangdong Zhongsheng Pharmaceutical Co., Ltd. carries a market capitalization of 24.64B, placing it among publicly traded companies globally. Its enterprise value stands at 11.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Guangdong Zhongsheng Pharmaceutical Co., Ltd. currently has 851.56M shares outstanding.

Valuation Ratios

Guangdong Zhongsheng Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 21.92. The price-to-sales ratio is 5.16, and the price-to-book ratio stands at 6.95.

Enterprise Valuation

On an enterprise value basis, Guangdong Zhongsheng Pharmaceutical Co., Ltd. trades at an EV/EBITDA multiple of 40.38 and an EV/FCF ratio of 45.88. The EV/Sales ratio of 4.94 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 40.38 provides insight into valuation relative to core operating earnings.

Financial Position

Guangdong Zhongsheng Pharmaceutical Co., Ltd. maintains a current ratio of 3.54, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.11, indicating elevated leverage, while an interest coverage ratio of 23.76 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Guangdong Zhongsheng Pharmaceutical Co., Ltd. has paid 48.23M in income taxes, reflecting an effective tax rate of 56.13.

Stock Price Statistics

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s stock has gained approximately 81.75549% over the past 52 weeks. The 50-day moving average sits at 22.21, while the 200-day moving average is 20.31.

Income Statement

Over the trailing twelve months, Guangdong Zhongsheng Pharmaceutical Co., Ltd. generated 2.40B in revenue and converted that into -198.67M in net income, yielding earnings per share of -0.32. EBITDA reached 293.76M, while operating income came in at 293.76M.

Balance Sheet

Guangdong Zhongsheng Pharmaceutical Co., Ltd. holds 1.17B in cash and equivalents against 530.29M in total debt, resulting in a net debt position of -576.31M. Total book value stands at 1.78B, with working capital of 2.24B providing operational flexibility.

Cash Flow

After subtracting -243.44M in capital expenditures, free cash flow totaled -243.44M - equivalent to -0.29 per share.

Margins

Guangdong Zhongsheng Pharmaceutical Co., Ltd. operates with a gross margin of 56.63, reflecting its pricing power and cost economics. The operating margin of 12.23 and net profit margin of -8.27 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s most recent stock split took place on September 1, 2015 with a 1:2 split ratio.

Scores

Guangdong Zhongsheng Pharmaceutical Co., Ltd. posts an Altman Z-Score of 8.41, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.